CardioCreate is a regenerative medicine company pioneering new treatments for heart disease. Unlike conventional therapies that treat the symptoms, CardioCreate’s engineered stem cells can actually rebuild damaged heart tissue and restore cardiac function. The company is currently generating preclin…
CardioCreate is a regenerative medicine company pioneering new treatments for heart disease. Unlike conventional therapies that treat the symptoms, CardioCreate’s engineered stem cells can actually rebuild damaged heart tissue and restore cardiac function. The company is currently generating preclinical data that it hopes will enable first-in-man testing within the next several years.
Team (1)
Sectors CardioCreate, Inc. serves:
Life Sciences
Health Care
Join Axial's Private M&A Platform
CardioCreate, Inc. connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.